Head-to-Head Studies for Plaque Psoriasis Therapies : vimars

Expert dermatologists highlight the benefits of head-to-head trials for various agents for the management of plaque psoriasis and review the top-line results of a study comparing risankizumab and apremilast.

Related Keywords

Benjamin Lockshin , Sandy Blauvelt , Bruce Strober , Jennifer Soung , , Plaque Psoriasis , Head To Studies , Skin Clearance Rates , Il 23 Inhibitors , Meta Analysis , Acumulative Effect , Durability , Risankisumab , Apremilast ,